Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
61.7M
-
Shares change
-
+1.25M
-
Total reported value, excl. options
-
$1.8B
-
Value change
-
+$64.5M
-
Put/Call ratio
-
1.39
-
Number of buys
-
98
-
Number of sells
-
-78
-
Price
-
$29.24
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q1 2024
223 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q1 2024.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.7M shares
.
Largest 10 shareholders include FARALLON CAPITAL MANAGEMENT LLC (5.59M shares), VANGUARD GROUP INC (5.57M shares), BlackRock Inc. (4.66M shares), Bellevue Group AG (4.01M shares), STATE STREET CORP (3.14M shares), ARMISTICE CAPITAL, LLC (2.96M shares), DIMENSIONAL FUND ADVISORS LP (2.58M shares), JPMORGAN CHASE & CO (2.47M shares), Erste Asset Management GmbH (2.28M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (2.01M shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.